We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Targeted Feedback Reports to Improve Acute Coronary Syndromes (ACS) Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00952250
Recruitment Status : Completed
First Posted : August 6, 2009
Last Update Posted : December 2, 2011
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
Duke University

Brief Summary:

This project is designed to examine the impact of tailored feedback on site performance.

The investigators' objective is to evaluate whether a 'personalized and targeted' feedback, education and performance improvement intervention has a greater impact on adherence to recommended guidelines than standard feedback.

The investigators hypothesize that a site-specific report with centrally identified targets for improvement paired with target specific interventions will enable sites to quickly identify and prioritize salient problem areas, have ready access to an analysis of factors that underlie problems, and formulate an effective action plan. The investigators also hypothesize that those hospitals randomized to receive intervention will be more likely to improve their overall performance, as well as their target specific performance, during the period of observation in direct response to activated QI processes.

Outcomes:

The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets.

The secondary outcome is improvement in the composite of targeted metrics.

Outcomes will be assessed in all participating sites, and in among relevant performance subgroups (low performers, academic centers, full service, and among medication versus process metrics).


Condition or disease Intervention/treatment
Acute Coronary Syndromes Behavioral: Targeted Feedback Reports Behavioral: Targeted Feedback Report

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 149 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Personalized and Targeted Feedback in the ACTION-Registry-GWTG
Study Start Date : February 2009
Primary Completion Date : July 2011
Study Completion Date : July 2011

Arm Intervention/treatment
Active Comparator: Targeted Feedback Reports
Conventional feedback reports
Behavioral: Targeted Feedback Reports
Sites randomized to this arm will receive specialized feedback summarizing their adherence to the guidelines and suggestions on ways to improve performance.
Experimental: Targeted Feedback Report
Report designed to target areas for local hospital-specific improvement.
Behavioral: Targeted Feedback Report
Report designed to target areas for local hospital-specific improvement



Primary Outcome Measures :
  1. The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets. [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. The secondary outcome is improvement in the composite of targeted metrics. [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hospitals participating in the ACTION Registry GWTG

Exclusion Criteria:

  • sites with low volume of data submission (< 10 data forms in the past year)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00952250


Locations
United States, North Carolina
Duke University Health System
Durham, North Carolina, United States, 27705
Sponsors and Collaborators
Duke University
Agency for Healthcare Research and Quality (AHRQ)
Investigators
Principal Investigator: Karen P Alexander, MD Duke University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT00952250     History of Changes
Other Study ID Numbers: Pro00010526
First Posted: August 6, 2009    Key Record Dates
Last Update Posted: December 2, 2011
Last Verified: December 2011

Keywords provided by Duke University:
quality improvement

Additional relevant MeSH terms:
Syndrome
Acute Coronary Syndrome
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases